Search results
Results listing
-
Eli Lilly and Company v Janssen Sciences Ireland UC (Formerly Janssen Alzheimer Immunotherapy)
High Court (Patents Court)
[2016] EWHC 313 (Pat)
Matching text sample:
...applied for an order that patent proceedings brought by the Claimant... ...the decision of the European Patent Office on the validity of... the divisional patent challenged in these proceedings.... ...specified claims of Janssen’s patent EP (UK) 2 305...
...history relating to the divisional patent and to the parent patent, EP 1 994 937... ...the EPO and the English Patent Court is as follows.... ...to revoke the UK parent patent and included in those proceedings... ...of solanezumab. The UK parent patent was held to be invalid...
the parent patent was not invalid on the...
claim 1 in the parent patent was novel and was not...
-
Varian Medical Systems International AG v Elekta Ltd & Anor
High Court (Patents Court)
[2017] EWHC 712 (Pat)
Matching text sample:
The Green patent
This case concerns patent EP (UK) 0 963... June 2005. The patent was filed on 21 ...is Michael Green and the patent is referred to as the... Green patent. The Green patent relates to a combination of...
...-Linac machine infringes the Green patent because it is able to...
...the cases regarding the Green patent’s validity and infringement relating...
-
Merck Sharp And Dohme Ltd v Shionogi & Co Ltd
High Court (Patents Court)
[2016] EWHC 2989 (Pat)
Matching text sample:
The Patent
...-examination of expert witnesses in patent cases
The data in the Patent
...has infringed Shionogi’s European Patent (UK) No. 1... ...“Antiviral agent” (“the Patent”). The allegation of... ...within the claims of the Patent. Both drugs are integrase... ...infringement and claims that the Patent should be revoked on the...
-
Novartis AG & Anor v Johnson & Johnson Medical Ltd & Ors
Court of Appeal (Civil Division)
[2010] EWCA Civ 1039
Matching text sample:
.... 0,819,258, the Patent was invalid. The ground... of invalidity was insufficiency (patent law jargon for failure to... ...&J’s contentions that the Patent was invalid for obviousness or... lack of novelty (patent law jargon for the latter...
...Judge’s decision that the Patent is not entitled to its... ...date of application for the Patent, as available prior art...
The Patent Claim
...types of polymerisable material. The patent calls one type “oxyperm”...
-
Glaxo Group Ltd v Genentech Inc & Anor
High Court (Patents Court)
[2007] EWHC 1416 (Pat)
Matching text sample:
The European Patent Office
The patent cases
Why are patent cases different?
European Patent No. 1 176 981... (“the patent”) was granted on 30... ...and Biogen Idec Inc. The patent designates 25 states, one... ...is a second medical indication patent which discloses and claims the...
-
Intervet UK Ltd v Merial R.'s University of Belfast the University of Saskatchewan
High Court (Patents Court)
[2010] EWHC 294 (Pat)
Matching text sample:
The Patent
...the joint proprietors of European Patent (UK) No. 1... ...and diagnostic reagents” (“the Patent”). The Patentees allege... ...infringed claim 18 of the Patent by marketing a vaccine known... ...and seeks revocation of the Patent.
The Patent has three claimed priority dates... ...on validity is whether the Patent is entitled to the first... ...the first priority document, French Patent Application No. 9712382, as... ...The Patentees contend that the Patent is entitled to the priority...
If the Patent is not entitled to the... ...Intervet’s case that the Patent is invalid over two items... ...); and (ii) International Patent Application No. WO 99/... ...which claims priority from US Patent Application No. 60/069,...
-
Pfizer Ltd v F. Hoffmann-La Roche AG & Anor
High Court (Patents Court)
[2019] EWHC 1520 (Pat)
Matching text sample:
...the Roche group) held a patent for bevacizumab itself. As... ...protection conferred by the basic patent continues until June 2020.... ...of second-line patents and patent applications which hinder Pfizer in...
The patents and patent applications all relate to combinations...
a patent being granted either before or...
...priority date for a given patent or application, bevacizumab in... defence to any patent claim should Roche sue at... ...regardless of when such a patent might be granted. An...
-
Coflexip SA v Stolt Offshore MS Ltd & Ors
High Court (Patents Court)
[2003] EWHC 1892 (Pat)
Matching text sample:
...sued Stolt for infringement of Patent. On 31
...J whereby he held the Patent valid and infringed. The... ...and product claim of the Patent. Laddie J ordered:
...acts of infringement of the Patent and of the rights conferred... ...of the application for the Patent by the Defendant and each...
...within the scope of the Patent as construed by the Court...
-
Chugai Pharmaceutical Co. Ltd v UCB Pharma SA & Ors
High Court (Patents Court)
[2018] EWHC 2264 (Pat)
Matching text sample:
Construction of the 771 patent
...case is about United States patent 7,566,771. The patent is entitled Humanised Antibodies and... ...John Emtage as inventors. The patent is licensed to the claimant... Chugai under a patent licence agreement between Chugai and...
...Valid Claim of the relevant patent …”
...of the claims of a patent which is in force in... ...territory, unless and until that patent expires or is finally held...
-
NGM Sustainable Developments Ltd v Wallis & Ors
High Court (Chancery Division)
[2015] EWHC 2089 (Ch)
Matching text sample:
...that it extended to a Patent Application (no PCT/GB1009/... 0050498) (“the Patent”) and all of its... ...intellectual property rights in any patent including the Patent. It also extended to...
The Patent was an application relating to... ...became available for development. The Patent itself was only an application...
ARRANGEMENTS AS REGARDS TO THE PATENT
...was the acquisition of the Patent. This was achieved appointing... ...exercise was to obtain the Patent. That was done by... ...The only bidder for the Patent was Lizzano in the sum...